Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Investor Presentation 2004

Jul 4, 2004

65124_rns_2004-07-04_f86e685c-d320-4e7f-bc45-b85a50822622.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

(Anggota An

LIMITED

INVITATION

TO AN

INVESTOR BRIEFING

To be held :

On Tuesday 13 July 2004

  • 3.30 pm to 4.30 pm At
  • On Level 6, BGC Building, 28 The Esplanade, Perth WA

Shareholders and investors are invited to attend an investor briefing on Imugene and its activities by Executive Chairman, Graham Dowland and Managing Director, Dr Warwick Lamb.

The Board is mindful of the broad geographic distribution of its shareholders and that the past two Annual General Meetings have been held in Sydney. Accordingly, presentations have and will continue to be made in other parts of Australia. The Board invites shareholders and investors to attend an Imugene Investor Briefing on Tuesday 13 July 2004 at 3.30 pm on Level 6 of the BGC Building.

We look forward to seeing you.

Graham Dowland & Warwick Lamb

ABN: 99 009 179 551 Level 1, 14 - 20 Delhi Road, North Ryde NSW 2113 PO Box 307, North Ryde NSW 1870 Tel: +61 2 9870 7330 Fax: +61 2 9888 9338 website: www.imugene.com